REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Biopronec CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Biopronec CIA Ltda Profile Updated: February 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Biopronec CIA Ltda is a company based in Ecuador, with its head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on January 18, 2008. It currently has a total number of 54 (2024) employees. In 2024, the company reported a net sales revenue increase of 8.04%. Its total assets grew by 6.89% over the same period.

Headquarters
Jose Carollo Oe1-238
Quito; Pichincha;

Contact Details: Purchase the Biopronec CIA Ltda report to view the information.

Website: http://www.pronavit.com

Basic Information
Total Employees:
Purchase the Biopronec CIA Ltda report to view the information.
Registered Capital:
Purchase the Biopronec CIA Ltda report to view the information.
Financial Auditors:
Purchase the Biopronec CIA Ltda report to view the information.
Incorporation Date:
January 18, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
47%
Purchase this report to view the information.
45%
Purchase this report to view the information.
4%
Purchase this report to view the information.
4%
Company Performance
Financial values in the chart are available after Biopronec CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
8.04%▲
Total operating revenue
8.94%▲
Operating profit (EBIT)
-44.58%▼
EBITDA
-34.46%▼
Net Profit (Loss) for the Period
N/A
Total assets
6.89%▲
Total equity
-0.56%▼
Operating Profit Margin (ROS)
-1.74%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
4.2%▲
Quick Ratio
0.29%▲
Cash Ratio
-0.04%▼

Similar companies

Quifatex S.A.
 
Laboratorios Siegfried S.A.
Roche Ecuador S.A.
 
Bayer S.A.
Nefrocontrol S.A.
 
Novartis Ecuador S.A.
Genericos Americanos, Genamerica S.A.
 
Laboratorio Phytochemie CIA Ltda
Vitaam-Vitaminas Aminoacidos y Minerales S.A.S.
 
Laboratorios Anyupa S.A.
Nutraceuticals & Life Pharma Laphifarma S.A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo